Transcranial magnetic stimulation (TMS) is a diagnostic method well established in neurology. As some effects of TMS are similar to those of electroconvulsive therapy (ECT), we looked for an antidepressant efficacy of TMS in a semi-blinded monocentric pilot study. Fifteen patients with Major Depress
Application of transcranial magnetic stimulation in treatment of drug-resistant major depression—a report of two cases
✍ Scribed by G. Höflich; S. Kasper; A. Hufnagel; S. Ruhrmann; H.-J. Möller
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 386 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We report the cases of two drug‐resistant major depressed psychotic patients, who were treated with 10 sessions of transcranial magnetic stimulations (TMS) and afterwards with 10 sessions of electroconvulsive therapy (ECT) without changing the concomitant neuroleptic and antidepressive medication. TMS did not exert a therapeutic effect in one patient and only a slight one in the other. However, there was a clear beneficial effect for ECT in the patient not responding to TMS and a slight therapeutic effect in the other. In summary, there was no clear‐cut evidence for effectiveness of TMS as a treatment for patients with psychotic, therapy resistant depression. However, since there was a slight therapeutic effect of TMS in one patient it seems worthwhile to explore its therapeutic efficacy in a larger group of depressed patients.
📜 SIMILAR VOLUMES
## Abstract Repetitive transcranial magnetic stimulation (rTMS) is a relatively new treatment modality for psychiatric patients. rTMS was demonstrated to be effective in the treatment of depression. However, longitudinal outcome studies have not yet been published. Relapse rates are higher in depre
Objective: To assess the efficacy of increasing the number of fast left repetitive transcranial magnetic stimulations (rTMS) (10 Hz @ 120% of motor threshold (MT) over the left dorsolateral prefrontal cortex (DLPFC)) needed to achieve remission in treatment-resistant depression (TRD). And, to determ
## Background: The majority of studies investigating the effectiveness of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression have focused on high-frequency rTMS to the left prefrontal cortex (HFL-rTMS). In addition, low-frequency right prefrontal rTMS (LFR-rTMS
## Objective: This study was designed to evaluate the potential efficacy of repetitive transcranial magnetic stimulation (rtms) at low-frequency in patients with major depression and schizophrenia. ## Experimental design: We investigated the therapeutic effect of a course of 10 rtms sessions in 1